Why SPACs Are Making a Quiet Comeback in 2026

Reports of the SPAC's Death Were Greatly Exaggerated

In 2021, SPACs (Special Purpose Acquisition Companies) raised over $160 billion across 613 IPOs. By 2023, annual SPAC IPO volume had cratered to under $4 billion. The hangover was brutal: hundreds of SPACs that failed to find targets returned capital to investors, sponsors lost hundreds of millions in at-risk capital, and the SEC implemented sweeping new regulations that many predicted would kill the structure entirely.

They were wrong. In 2025, SPAC IPO volume recovered to approximately $18 billion across 85 transactions — still a fraction of the bubble peak, but a meaningful recovery from the trough. More importantly, the quality and structure of new SPACs have improved materially. The market is no longer dominated by celebrity sponsors and speculative de-SPAC targets. The 2026 vintage is shaping up to be the most investor-friendly in SPAC history.

What Changed: Regulation and Market Discipline

SEC Reforms

The SEC's January 2024 SPAC reform rules fundamentally altered the economics:

• Enhanced disclosure requirements: SPACs must now provide the same level of financial disclosure as traditional IPOs, including projections that are no longer shielded by safe harbor provisions. This eliminates the "forward-looking statement" loophole that allowed de-SPAC targets to present aggressive, unaudited revenue projections.
• Underwriter liability: Investment banks that underwrite SPAC IPOs now face the same liability as traditional IPO underwriters for the subsequent de-SPAC transaction. This has dramatically increased the quality of due diligence performed on target companies.
• Dilution disclosure: SPACs must now clearly disclose the dilutive impact of sponsor promotes, warrants, and other structural features. Investors can no longer claim they didn't understand the cost of the blank-check structure.

Structural Evolution

Market discipline has forced sponsors to offer significantly better terms:

• Reduced promotes: The traditional 20% sponsor promote (where the SPAC sponsor receives 20% of post-IPO equity for minimal investment) is being replaced by structures with 10–15% promotes, or promotes that only vest upon achieving post-merger share price targets.
• At-risk capital: Sponsors are now putting up 3–5% of trust value in at-risk capital, compared to 1–2% during the bubble. This creates meaningful alignment with public shareholders.
• Shorter timelines: New SPACs are targeting 12–18 month deal timelines versus the 24-month standard of the bubble era, reducing the opportunity cost for investors who park capital in trust.
• Reduced warrant dilution: Many new SPACs have eliminated public warrants entirely or reduced coverage to 1/3 or 1/4 of a warrant per unit, meaningfully reducing post-merger dilution.

Who's Behind the New Wave

The sponsor landscape has shifted decisively toward institutional quality. The celebrities, athletes, and first-time sponsors who populated the 2021 vintage have largely exited the market. The current cohort includes:

<

ul>

Experienced repeat sponsors who have completed successful de-SPACs and generated positive returns for shareholders

Private equity firms using SPACs as an alternative exit path for portfolio companies

Industry operators with deep domain expertise in specific sectors (defense technology, healthcare services, energy transition)

Sovereign wealth fund-backed sponsors targeting cross-border acquisitions

This matters because sponsor quality is the single most important predictor of de-SPAC outcomes. Research by the Stanford Law School found that SPACs led by experienced financial sponsors outperformed first-time sponsors by approximately 30 percentage points in post-merger stock performance over 12 months.

Where the Targets Are

The current SPAC pipeline is concentrated in sectors where private companies face genuine barriers to traditional IPO:

• Defense and aerospace technology: Companies with classified government contracts that cannot provide full financial disclosure in a traditional S-1 filing process
• Energy transition and infrastructure: Capital-intensive companies with long development timelines that benefit from the certainty of SPAC merger consideration versus the volatility of a traditional IPO window
• Healthcare services and medtech: Companies with regulatory milestones that are better suited to the fixed-price SPAC merger structure
• AI infrastructure: Data center operators, chip design companies, and AI services firms seeking faster access to public markets

Performance Reality Check

Let's be honest about the historical record. The De-SPAC Index, which tracks post-merger performance of SPAC targets, is still down approximately 70% from its 2021 peak. The median de-SPAC from the 2020–2021 vintage has destroyed substantial shareholder value.

But aggregate statistics obscure important nuances. Among SPACs from those vintages led by experienced financial sponsors targeting companies with over $100M in trailing revenue, the outcomes were significantly better — median post-merger returns of approximately -5% versus -40% for the broader universe. Still negative, but a world apart from the catastrophic losses in speculative, pre-revenue de-SPACs.

Early data from 2024–2025 vintage de-SPACs is more encouraging. With better structures, more realistic valuations, and higher-quality targets, the cohort is tracking roughly in line with traditional IPO performance — which is exactly what you'd expect from a mature, well-regulated market.

Investment Strategy for the SPAC Comeback

For sophisticated investors, the reformed SPAC market offers several distinct strategies:

Pre-Deal Trust Arbitrage

SPAC units trading at or below trust value ($10.00–$10.50 per share) offer a near-risk-free return profile pre-deal: you hold a T-bill equivalent with optionality on a value-creating merger. Current risk-free yields mean pre-deal SPACs effectively offer 4.5–5.0% annualized returns with equity upside optionality. The downside is limited because you can always redeem for trust value. This is the lowest-risk way to participate.

Selective De-SPAC Participation

When a de-SPAC is announced, evaluate it as you would any public market investment: on fundamentals, valuation, and management quality. Ignore the SPAC wrapper and ask whether you would buy the target company at the proposed valuation in a traditional IPO. If the answer is no, redeem your shares.

PIPE Participation

Private investments in public equity (PIPE) that accompany de-SPAC transactions are often available to accredited investors at discounts to the merger price. PIPE investors typically get better economics than public SPAC shareholders, though they accept lockup restrictions. For investors with $250K+ to commit, PIPE participation in quality de-SPACs offers an attractive risk-adjusted entry point.

The Bottom Line

SPACs in 2026 are not SPACs in 2021. The regulatory framework is stronger, the structures are more investor-friendly, and the sponsor quality has improved dramatically. The excesses have been purged, and what remains is a viable — if niche — path to public markets that can generate attractive returns for disciplined investors.

Our view: allocate 3–5% of your public equity sleeve to pre-deal SPAC positions as a capital-efficient way to generate risk-free yield with equity optionality. Be highly selective on de-SPAC participation, focusing exclusively on profitable companies with experienced sponsors and reduced promote structures. The SPAC is no longer a get-rich-quick vehicle — it's a financial tool that, when used properly, can offer genuine value to both companies and investors.